medtech

Market Access

Balancing innovation and safety: The impact of Medtech regul...

The Medtech sector is currently at a crossroads, facing a potential choice between rapid technological advancement and strict regulatory oversight.

News

Mallinckrodt sells Therakos unit on at a discount

Ireland-headquartered pharma group Mallinckrodt has agreed to divest its subsidiary Therakos to private equity firm CVC Capital Partners for $925 million, well below the $1.33 billion it pa

Digital

Embracing innovation to drive clinical change in UK stroke c...

Medical technology (MedTech) companies go through a vigorous process to introduce their solutions into a clinical environment.

R&D

Could Amazon or Google hold the key to the future of public ...

Anyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximising the availability of self-testing and playing its part in th

News

NICE, NHS England unveil new pathway for medtech

Feedback is being sought on a proposed pathway that aims to accelerate access to new medical technologies by laying out a common set of rules and commissioning principles.

R&D

London’s life sciences scene upbeat as 2024 conference seaso...

With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.